0
There are 94 products.
Category: synthetic peptide (GHRP)
Active substance: Growth Hormone Releasing Peptide-6 (increase in growth hormone and IGF-1 levels, improved sleep, fat reduction)
Packaging: 10 mg/vial
Manufacturer: General Pharmaceuticals
Half-life: approx. 0.5 to 1 hour
Abused dose: 100 to 300 mcg daily
Category: Injectable compounds
Active ingredient: Human chorionic gonadotropin (HCG)
Packaging: 1 ampoule / 5000 IU
Manufacturer: General Pharmaceuticals
Half-life: 24 to 36 hours
Abused dose: 500 to 1500 IU once every 3 to 5 days
Category: Injectable Compounds (Peptide Hormone)
Active Ingredient: IGF-1 LR3
Packaging: Vial containing 1 mg
Manufacturer: General Pharmaceuticals
Half-Life: Estimated at 2-3 hours
Category: Synthetic peptide (GHRP)
Active ingredient: Ipamorelin
Packaging: 2 mg/vial
Manufacturer: General Pharmaceuticals
Half-life: approx. 2 hours
Abused dose: 100 to 300 mcg daily
Kategorie: Injektionspräparate (MT-I-Derivat, Peptidhormon)
Wirkstoff: Melanotan II
Packung: Vial mit 10 mg Inhalt
Hersteller: General Pharmaceuticals
Halbwertszeit: Bis zu 1 Stunde
Dosierung: Beginnend mit 250 mcg (0,25 mg) bis zu 1 bis 1,5 mg als tägliche Einzeldosis
Category: Injectable Substances (Melanotan 2 Derivative, Peptide Hormone)
Active Ingredient: bremelanotide
Packaging: Vial containing 10 mg
Manufacturer: General Pharmaceuticals
Half-life: 2 to 4 hours
Dosage: Taken in a single dose of 0.5 to 3 mg
Category: Injectable Substances (Peptide Hormone)
Active Ingredient: Thymosin Beta 4
Packaging: Vial containing 10 mg
Manufacturer: General Pharmaceuticals
Half-life: 3.5 to 7 hours
Dosage: Taken at a dose of 2.5 to 6 mg per week, with the dose divided into 2 to 3 doses per week
Category: Injectable Substances (GLP-1 Receptor Agonist, weight-loss medication)
Active Ingredient: Semaglutide
Packaging: Vial containing 4 mg
Manufacturer: General Pharmaceuticals
Half-life: approximately 7 days
Dosage: Most commonly 0.5 to 1 mg weekly (from 0.25 to 1 mg weekly)
Category: Injectable compounds (GLP-1 and GIP receptor agonist, medication for weight loss support)
Active ingredient: Tirzepatide
Packaging: Vial containing 10 mg
Manufacturer: General Pharmaceuticals
Half-life: approximately 5 days
Dosage: Most commonly 2.5 to 15 mg weekly (typically starting at 2.5 mg per week with gradual dose escalation based on tolerance)
Category: Injectable compounds (GLP-1, GIP, and glucagon receptor agonist; experimental weight loss medication)
Active ingredient: Retatrutide
Packaging: Vial containing 10 mg
Manufacturer: General Pharmaceuticals
Half-life: approximately 5–7 days
Dosage: Most commonly 2.5 to 12 mg weekly (typically titrated gradually based on tolerance)